Juntra Karbwang

Nagasaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Retraction Note: Preclinical studies of toxicity and anti-cholangiocarcinoma activity of the standardized capsule formulation of atractylodes lancea (Thunb.) DC.

Retraction Note: Preclinical studies of toxicity and anti-cholangiocarcinoma activity of the standardized capsule formulation of atractylodes lancea (Thunb.) DC.

Journal: BMC complementary medicine and therapies

Published: February 20, 2026

COVID-19 and ethics in action: Insights from African research committees.

COVID-19 and ethics in action: Insights from African research committees.

Journal: Journal of public health in Africa

Published: July 15, 2025

A checklist for translating and adapting questionnaires (CTAQ) in healthcare research: insights from a Delphi method approach.

A checklist for translating and adapting questionnaires (CTAQ) in healthcare research: insights from a Delphi method approach.

Journal: Tropical medicine and health

Published: July 06, 2025

Immunomodulatory Effects of Atractylodes lancea in Healthy Volunteers with Dosage Prediction for Cholangiocarcinoma Therapy: A Modelling Approach.

Immunomodulatory Effects of Atractylodes lancea in Healthy Volunteers with Dosage Prediction for Cholangiocarcinoma Therapy: A Modelling Approach.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 23, 2024

Interleukin-6 and Lymphocyte-to-Monocyte Ratio Indices Identify Patients with Intrahepatic Cholangiocarcinoma.

Interleukin-6 and Lymphocyte-to-Monocyte Ratio Indices Identify Patients with Intrahepatic Cholangiocarcinoma.

Journal: Biomedicines

Published: February 26, 2024

Pharmacokinetic Analysis of Prognostic Factors in Patients With Advanced-Stage Intrahepatic Cholangiocarcinoma Following the Administration of Capsule Formulation of the Standardized Extract of Atractylodes lancea (Thunb) DC.

Pharmacokinetic Analysis of Prognostic Factors in Patients With Advanced-Stage Intrahepatic Cholangiocarcinoma Following the Administration of Capsule Formulation of the Standardized Extract of Atractylodes lancea (Thunb) DC.

Journal: Integrative cancer therapies

Published: January 31, 2024

Population-pharmacokinetic/pharmacodynamic model of atractylodes lancea (Thunb.) DC. administration in patients with advanced-stage intrahepatic cholangiocarcinoma: a dosage prediction.

Population-pharmacokinetic/pharmacodynamic model of atractylodes lancea (Thunb.) DC. administration in patients with advanced-stage intrahepatic cholangiocarcinoma: a dosage prediction.

Journal: BMC complementary medicine and therapies

Published: December 13, 2023

The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey.

The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey.

Journal: F1000Research

Published: December 07, 2023

Preclinical studies of toxicity and anti-cholangiocarcinoma activity of the standardized capsule formulation of Atractylodes lancea (Thunb.) DC.

Preclinical studies of toxicity and anti-cholangiocarcinoma activity of the standardized capsule formulation of Atractylodes lancea (Thunb.) DC.

Journal: BMC complementary medicine and therapies

Published: February 02, 2023

In Silico Prediction of Andrographolide Dosage Regimens for COVID-19 Treatment.

In Silico Prediction of Andrographolide Dosage Regimens for COVID-19 Treatment.

Journal: The American journal of Chinese medicine

Published: August 28, 2022

Perspective: repurposed drugs for COVID-19.

Perspective: repurposed drugs for COVID-19.

Journal: Archives of medical science : AMS

Published: June 15, 2022

The Role of Herbal Medicine in Cholangiocarcinoma Control: A Systematic Review.

The Role of Herbal Medicine in Cholangiocarcinoma Control: A Systematic Review.

Journal: Planta medica

Published: April 25, 2022

Showing 1-12 of 62

Last Updated: 09/26/2026